Back

Age and risk scores for detecting coronary artery calcification in heterozygous familial hypercholesterolemia

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (3) Scores ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Otavio Decanini Cantarella Silva

Sao Paulo (Brazil)

5 More presentations in this session

Presentation thumbnail
Influence of the non-lipoprotein(a) apolipoprotein B/lipoprotein(a) ratio and other risk factors on coronary arterial aterosclerotic burden in acute coronary syndrome.
Doctor A. Meseguer Hernandez (Cartagena, ES)
Abstract Slides Video
Presentation thumbnail
High-sensitive CRP is a reliable biomarker for predicting events in a cardiovascular population
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) measurements identify patients with elevated likelihood of obstructive coronary artery disease despite very low or low clinical likelihood
Doctor G. Brix (Herning, DK)
Abstract Slides Video
Presentation thumbnail
Risk of cardiovascular events in U.S. patients using the SMART risk score
Doctor D. Fernandez Vazquez (Lorca, ES)
Abstract Slides Video
Presentation thumbnail
A 4-protein biomarker risk score enhances cardiovascular risk assessment: insights from the multi-ethnic study of atherosclerosis
Assistant Professor J. Medina-Inojosa (Atlanta, US)
Abstract Slides

Access the full session

Session thumbnail
Risk factors (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Coronary calcium score may better discriminate against high-risk subjects with little conventional cardiovascular risk factors
thumbnail
Congress Presentation
Age at diagnosis determines coronary artery risk in familial hypercholesterolemia: a population-based study
thumbnail
Congress Presentation
The role of coronary artery calcium score and european score2 in primary prevention of cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources